Relationship of unilateral total hip arthroplasty (THA) to contralateral and ipsilateral knee joint degeneration – a longitudinal 3T MRI study from the Osteoarthritis Initiative (OAI)  by Jungmann, P.M. et al.
Osteoarthritis and Cartilage 23 (2015) 1144e1153Relationship of unilateral total hip arthroplasty (THA) to contralateral
and ipsilateral knee joint degeneration e a longitudinal 3T MRI study
from the Osteoarthritis Initiative (OAI)
P.M. Jungmann y z *, M.C. Nevitt x, T. Baum z, H. Liebl y, L. Nardo y, F. Liu x, N.E. Lane k,
C.E. McCulloch x, T.M. Link y
y Musculoskeletal and Quantitative Imaging Research, Department of Radiology and Biomedical Imaging, University of California San Francisco, 185 Berry
Street, Suite 350, San Francisco, CA 94107, USA
z Department of Radiology, Technische Universitaet Muenchen, Ismaninger Strasse 22, 81675 Munich, Germany
x Department of Epidemiology and Biostatistics, University of California San Francisco, 185 Berry Street, Suite 5700, San Francisco, CA 94107, USA
k Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA 95817, USAa r t i c l e i n f o
Article history:
Received 6 October 2014
Accepted 15 March 2015
Keywords:
Hip arthroplasty
Osteoarthritis
Knee
Cartilage
T2 measurements
WORMS* Address correspondence and reprint requests to:
of Radiology, Technische Universitaet Muenchen, Is
Munich, Germany. Tel: 49-(0)-89-4140 2621; Fax: 49
E-mail addresses: pia.jungmann@tum.de (P.M. Ju
edu (M.C. Nevitt), thomas.baum@tum.de (T. B
(H. Liebl), lorenzo.nardo@ucsf.edu (L. Nardo), ﬂiu@
lane@ucdmc.ucdavis.edu (N.E. Lane), cmcculloch@p
thomas.link@ucsf.edu (T.M. Link).
http://dx.doi.org/10.1016/j.joca.2015.03.022
1063-4584/© 2015 Osteoarthritis Research Society Ins u m m a r y
Objective: To evaluate the association of prevalent unilateral total hip arthroplasty (THA) with worsening
of degenerative knee abnormalities and clinical outcomes in the ipsilateral and contralateral knee.
Methods: Both knees of 30 individuals in the Osteoarthritis Initiative (OAI) with unilateral THA (n ¼ 14
left, n ¼ 16 right) at baseline were assessed at baseline and at 4-year follow-up for Whole-organ MR
Imaging Scores (WORMS), cartilage T2 relaxation times (only available for right knees), Western Ontario
and McMasters Universities Arthritis Index (WOMAC) scores and upper leg isometric strength. Right
knees of 30 individuals without THA were analyzed as controls. Contralateral knees were compared to
ipsilateral knees with paired t-tests and to control knees with multivariate regression analysis adjusting
for covariates.
Results: In paired analyses, compared to ipsilateral knees, contralateral knees had higher WORMS total
(P ¼ 0.008) and cartilage scores (P ¼ 0.007) at baseline. Over 4 years contralateral knees worsened more
on WORMS total score (P ¼ 0.008). Cartilage T2 values were higher in knees contralateral to the THA
(baseline, P ¼ 0.02; follow-up, P < 0.001). Contralateral knees had greater declines in knee extension
strength (P ¼ 0.04) and had a trend for greater worsening in WOMAC pain, stiffness, function and total
scores (P ¼ 0.04e0.09). Similar results were found comparing contralateral knees with control knees in
multivariate regression models.
Conclusions: Prevalent unilateral THA is associated with an greater progression of degenerative ﬁndings
for the knee contralateral to THA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) of the knee or hip joint is a major cause for
disability in our aging society1. Joint degeneration of one large jointP.M. Jungmann, Department
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ternational. Published by Elsevier Lis associated with degenerative changes in other large joints2.
Interestingly, patients with unilateral total hip arthroplasty (THA)
have a higher rate of total knee replacements on the contralateral
side rather than the ipsilateral side3,4. However, the association of
THA with degenerative changes in the ispi-versus contralateral
knee is not well understood. No longitudinal follow-up studies have
evaluated the inﬂuence of unilateral THA on knee pain and function
or on degenerative changes at the knee joint assessed with MRI5.
MRI provides detailed information on morphological abnormalities
in OA6,7. Recently, T2 mapping techniques have been developed to
visualize and quantitatively evaluate early cartilagematrix damage,
mainly collagen disruption and elevation of cartilage water
content8,9.td. All rights reserved.
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NIH initiated multi-center, prospective observational study of knee
OA (https://oai.epi-ucsf.org/datarelease/StudyOverview.asp). The
overall aim is to develop a public domain research resource to
facilitate the scientiﬁc evaluation of biomarkers for OA as potential
surrogate endpoints for disease onset and progression. Four clinical
centers and a data coordinating center conduct the OAI, a public-
private partnership, that bring together new resources and
commitment to help ﬁnd biochemical, genetic and imaging bio-
markers for development and progression of OA. The OAI estab-
lishes andmaintains a natural history database for OA that includes
clinical evaluation data, radiological images, and a biospecimen
repository from 4796 men and women10.
The purpose of this study was to determine the association of
prevalent unilateral THA with degenerative changes at the ipsilat-
eral and contralateral knee at baseline and in a 4 year longitudinal
follow-up. We hypothesized that unilateral THA is associated with
more advanced degenerative changes (3T MRI assessment), knee
symptoms and muscle weakness in the contralateral compared to
the ipsilateral knee, and in particular, that these ﬁndings show
greater progression in contralateral knees over 4 years.Methods
Subjects
Individuals from the OAI with a unilateral THA at baseline were
included in the study if they had nometallic implants in either knee
at either time-point, no additional THA at the contralateral hip at
the 4 year follow-up and had complete MRIs in both knees at
baseline and 4 year follow-up. There were 30 subjects with a uni-
lateral THA (14 left, 16 right) whomet these criteria (23/30 from the
OAI incidence cohort, 7/30 from the OAI progression cohort). As a
reference group, 30 subjects without THA were age, gender, Body
mass index (BMI) and OAI cohort matched (24/30 from the OAI
incidence cohort, 6/30 from the OAI progression cohort). The pro-
cedures followed were in accordance with the ethical standards of
the responsible committee on human experimentation (institu-
tional and national) and with the Helsinki Declaration of 1975, as
revised in 2000. The study protocol, amendments, and informed
consent documentation were approved by the local institutional
review boards. Speciﬁc OAI datasets used in this study were base-
line datasets 0.2.2 and 0.E.1 and the 4 year follow-up datasets 6.2.1
and 6.E.1 (http://www.oai.ucsf.edu/).Imaging: pelvic and knee radiography
Bilateral standing anterior-posterior pelvic radiographs and
posterior-anterior knee radiographs were acquired (http://oai.epi-
ucsf.org/datarelease/OperationsManuals.asp). Pelvic radiographs
were screened for presence of unilateral THA at baseline and year 4.
Baseline KellgreneLawrence (KeL) scores for both knees of each
individual were obtained from the OAI database (central KeL
readings).Imaging: knee MRI
MRI sequences for semiquantitative Whole-organ MR Imaging
Scores (WORMS) readings and for quantitative T2 mapping were
acquired in right knees at four clinical sites using 3T MRI scanners
(Siemens Magnetom Trio; Siemens, Erlangen, Germany) and
quadrature transmit-receive knee coils (USA Instruments, Aurora,
OH). Details of the acquisition protocol are given in Table I11.Semi-quantitative morphological knee MRI analyses
Morphological MR images (Table I) of both knees of the unilat-
eral THA subjects and of right knees of those without a THA were
assessed for OA-related abnormalities using a modiﬁed
WORMS12,13. MR images were reviewed on picture archiving
communication system (PACS) workstations (Agfa, Ridgeﬁeld Park,
NJ). MRIs were evaluated by two musculoskeletal radiologists
separately (P.M.J., L.N.; 6 and 8 years of experience, respectively),
blinded for the THA side and for the time-point; if scores were not
identical consensus readings by both radiologists and a third in-
dependent radiologist (T.M.L., 23 years of experience) were per-
formed. A total WORMS summation score, with a potential
maximum of 110 was calculated as the sum of grades for all of the
knee features: (1) meniscus abnormalities (score 0e4 in six re-
gions), (2) cartilage lesions (score 0e6 in six regions), (3) bone
marrow lesions (score 0e3 in six regions) (4) ligament abnormal-
ities (score 0e4 in six locations), and (5) other abnormalities
(effusion (0e3), intraarticular body (0e2), baker cyst (0e3)).
Additionally, meniscus scores were calculated for the medial and
for the lateral meniscus (score 0, all meniscus subregions “0”; score
1, no > 1; score 2, “2” in one subregion; score 3, “2” in >1 subregion;
score 4, “3” in 1 subregion; score 5, “4” in one subregion; score 6,
“4” in 1 subregion). For the parameters cartilage, bone marrow
lesions, ligament abnormalities and other abnormalities maximum
scores were determined, indicating the maximum score of all
subregions for each parameter. The total maxWORMS score with a
potential maximum of 28 was deﬁned as the sum of the meniscus
scores and the maximum scores.
T2 relaxation time measurements
T2 mapping MSME spin echo sequences, available for all right
knees were analyzed on a remote workstation (SPARC; Sun
Microsystems, Mountain View, CA) using an in-house software
implemented in MATLAB (The Mathworks Inc., Natick, MA)14e16.
Semi-automated spline-based segmentationwas performed by two
radiologists (P.M.J. and H.L.; 6 and 2 years of experience) under
supervision of an experienced radiologist (T.M.L.; 23 years of
experience) in ﬁve compartments: (1) patella, (2) medial and (3)
lateral femoral condyle and (4) medial and (5) lateral tibia. The
trochlea was excluded because of interfering ﬂow artifacts from the
popliteal artery. Segmentation was performed on all slices of the
ﬁrst echo images. T2 maps were created using a monoexponential
decay model as ﬁtting function to calculate the signal intensity at
the different echo times. T2 calculations were measured from the
second (20 ms) to the last (70 ms) echo images, dropping the ﬁrst
echo time17e19. T2 values of baseline and 4-year follow-up time
points were calculated. “Global” T2 value was deﬁned as mean of all
compartments combined. Four-year progression was calculated as
the difference (T2 follow-upT2 baseline). Since T2 mapping sequences
were only available for right knees, comparisons of T2 values be-
tween the groups were non-paired. The “contralateral THA” group
was represented by the 14 individuals with a left THA and the
“ipsilateral THA” group was represented by the 16 individuals with
a right THA.
Reproducibility of MRI measurements
Reproducibility was calculated in a randomly selected sample of
10 OAI subjects. For WORMS measurements, images were graded
twice by two radiologists (P.M.J., L.N.) on two separate occasions (2
weeks in-between) and linear weighted Cohen's Kappa values were
calculated. For cartilage defects, inter-observer kappa was 0.89,
intra-observer kappa was 0.91 and 0.95, respectively. For meniscus
Table I
MR pulse sequences
Parameter 2D IM-w FSE 3D DESS WE 3D T1-w FLASH WE 2D IM-w FS FSE 2D T2-w MSME SE
Plane Coronal Sagittal Coronal Sagittal Sagittal
Field of view (FOV; mm) 140 140 160 160 120
Matrix 128256 307384 512512 313448 269384
Number of slices 35 160 80 37 21
Slice thickness (mm) 3 0.7 1.5 3 3
Repetition time (RT; ms) 3700 16.3 20 2700 3200
Echo time (ET; ms) 29 4.7 7.6 10,20,30,40,50,60,70 30
Refocusing ﬂip angle () 180 25 12 180 n/a
Bandwidth (Hz/Pixel) 352 185 130 248 250
Echo train length 7 1 1 5 1
Acquisition time (min) 3.4 10.6 8.6 4.7 10.6
IM-w, intermediate-weighted; FSE, fast spin echo; DESS, dual-echo steady-state; WE, water-excitation; FLASH, fast low-angle shot; 3D, three-dimensional; 2D, two-
dimensional; FS, fat saturated; MSME, multislice-multiecho; SE, spin echo.
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0.89 and 0.95. For ligament abnormalities, inter-observer kappa
was 0.65, intra-observer kappawas 0.76 and 0.77. For bone marrow
abnormalities, inter-observer kappawas 0.80, intra-observer kappa
was 0.81 and 0.87. For other scorings, inter-observer kappa was
0.70, intra-observer kappa was 0.79 and 0.79. Inter-observer
agreement for T2 measurements (coefﬁcient of variation) was
described previously with an inter-reader reproducibility error for
mean T2 of 1.57%, respectively 0.53 ms13. Mean intra-reader
reproducibility for T2 measurements was 1.66%, respectively
0.55 ms.
Western Ontario and McMasters Universities Arthritis Index
(WOMAC)
Knee symptoms assessed by WOMAC (University of Western
Ontario and the McMaster University in Canada) scores in both
knees20,21. The WOMAC score is an established multidimensional
health status instrument. It quantiﬁes the degree of three different
domains of disease status (pain, stiffness and functional impair-
ment) through a 5-point scale (none, slight, moderate, severe and
extreme), with higher scores indicating increasing disease severity.
Physical activity scale for the elderly (PASE)
Physical activity levels were measured using the PASE score22,23.
The PASE score aims to assess general activity and health status in
older adults. This established score includes questions on house-
hold chores and occupational activities, as well as individual ac-
tivities such as knee bending, squatting and stair climbing. It has a
scale range from 0 to 400 andwas described as valid and reliable for
epidemiologic studies.
Isometric strength
Isometric strengthmeasurements were performed using a Good
Strength apparatus (Metitur, Jyv€askyl€a, Finland; www.oai.ucsf.edu/
datarelease/OperationsManuals.asp) for knee ﬂexion and exten-
sion. Two submaximal practice trials were completed before force
was measured three times for 3 s, each separated by 30 s; the
highest value for a limb is used for maximal strength reported (N).
Other baseline measurements
Heberden's nodes were considered present if bony enlarge-
ments were found in 3 DIP joints in either hand during an ex-
amination of the hand at baseline (http://oai.epi-ucsf.org/
datarelease/forms.asp). History of knee injury or surgery, familialpredisposition of OA, deﬁned as a total knee replacement for OA in a
biological parent or sibling, were assessed by self-report (https://
oai.epi-ucsf.org/datarelease/operationsManuals.asp). BMI was
calculated as weight in kg/height m2.
Statistical analysis
Statistical analysis was performed with JMP software Version 9
(SAS Institute, Cary, NC, USA). The analyses compared knees
contralateral to THAwith knees ipsilateral to THA andwith knees of
controls without THA for change in measures of knee OA over
4 years, for baseline scores and for scores at year 4 of follow-up.
Paired t-tests were used to compare outcomes between paired
ipsilateral and contralateral knees in the same subject. Multivari-
able linear regression was used for comparisons between contra-
lateral and control knees in different subjects and for comparisons
of T2. From the regression models adjusted means and standard
errors (SEM), adjusted mean differences and 95% conﬁdence in-
tervals were obtained. Covariates were OA risk factors including:
self-reported history of knee injury or surgery, familial predispo-
sition of OA, deﬁned as a total knee replacement for OA in a bio-
logical parent or sibling, Heberden's nodes, age, gender BMI and
PASE score. Sensitivity analyses were also performed by including
preexisting knee OA (KeL grade) at baseline as a covariate in mixed
model ﬁts (Stata Ver 13, College Station, TX, USA) and in the linear
regression models. The level of signiﬁcance was set at P < 0.05.
Results
Baseline characteristics
There were no statistically signiﬁcant differences in gender, age,
BMI or physical activity between subjects with unilateral THA and
controls with no THA (P > 0.05; Table IIA). Subjects with a THA in
the left hip (i.e., the right knee is ‘contralateral’ and also used in
comparisons to right control knees) had lower PASE physical ac-
tivity scores than controls (113 ± 47 vs 158 ± 73, P ¼ 0.04). KeL
grades were signiﬁcantly different between the groups (Table IIB).
WOMAC
WOMAC scores of knees contralateral to prevalent THA wors-
ened on average over 4 years (Total score, 2.0 ± 2.6) while
improving in ipsilateral knees (Total score, 3.4 ± 2.6, P ¼ 0.06;
Table III). WOMAC scores in control knees also improved during
follow-up (Total score,2.3± 2.6; contralateral vs control, P¼ 0.13).
Baseline WOMAC scores in contralateral knees were not signiﬁ-
cantly different compared to ipsilateral knees (Total scores,
Table IIa
Baseline characteristics. 2A. Subject characteristics by baseline THA status. BL ¼ Baseline; SD ¼ Standard deviation; PASE ¼ Physical Activity Scale for the Elderly; THA ¼ Total
hip arthroplasty; R ¼ right; L ¼ left
BL characteristic Subjects with
1. Unilateral THA 2. Unilateral THA in L hip 3. Unilateral THA in R hip 4. Controls, No THA
Subjects (n) 30 14 16 30
Gender (n; Male/Female) 43% (13/17) 43% (6/8) 44% (7/9) 47% (14/16)
Age ± SD (years) 67 ± 10 67 ± 10 67 ± 11 66 ± 10
Body mass index ± SD (kg/m2) 28.5 ± 4.3 28.8 ± 3.4 28.2 ± 4.9 27.9 ± 4.7
PASE ± SD 127 ± 53 113 ± 47* 140 ± 56 158 ± 73
* 2 vs 4, P ¼ 0.038. All other comparisons are NS, P > 0.05.
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score, 8.8 ± 2.3, P¼ 0.38; Table III). Adjusting for baseline KeL grade
had little impact on these comparisons, except that worsening in
WOMAC total (P ¼ 0.03) and function (P ¼ 0.03) scores were now
signiﬁcantly greater in contralateral vs ipsilateral knees.Morphological analysis of knee abnormalities (WORMS)
While WORMS scores tended to worsen during follow-up in all
knees, the increase in contralateral knees was greater than ipsi-
lateral knees for total score (7.9 ± 1.1 vs 4.6 ± 1.1, P ¼ 0.008;
replacing the sum score with the maximum score of bone marrow
lesions in the totalWORMS score, P¼ 0.03; total maxWORMS score,
P ¼ 0.05) and ligaments (2.4 ± 0.5 vs 0.8 ± 0.5, P ¼ 0.01; ligament
maximum score, P ¼ 0.10) and compared to control knees for total
score (P¼ 0.03; total maxWORMS score, P¼ 0.04), medial meniscus
(P ¼ 0.009; medial meniscus score, P ¼ 0.008) and ligaments
(P ¼ 0.009; ligament maximum score, P ¼ 0.13) (Table III). Baseline
WORMS scores in contralateral knees were signiﬁcantly worse
compared to ipsilateral knees for cartilage of the whole knee
(13.4 ± 1.2 vs 10.1 ± 1.2, P ¼ 0.007; cartilage maximum score,
P ¼ 0.06), medial meniscus (2.9 ± 0.4 vs 2.0 ± 0.4, P ¼ 0.01; medial
meniscus score, P ¼ 0.01) and total WORMS scores (28.1 ± 2.4 vs
21.3 ± 2.4, P ¼ 0.008; replacing the sum score with the maximum
score of bone marrow lesions in the total WORMS score, P ¼ 0.006;
total maxWORMS score, P ¼ 0.008) and compared to control knees
for cartilage and lateral meniscus (P < 0.05; Table III). In analyses
adjusting for baseline KeL grade, results for worsening of WORMS
scores were largely unchanged (total WORMS score, P ¼ 0.02),
although no longer signiﬁcant for contralateral vs ipsilateral liga-
ments (P ¼ 0.07) nor for contralateral vs control knee total score
worsening (P ¼ 0.07). After KeL adjustment no signiﬁcant differ-
ences in baselineWORMS scores between groups were found (total
WORMS score, P ¼ 0.71).
ExaminingWORMS cartilage scores in individual cartilage plates
(Table IV), there were no signiﬁcant differences for change in
cartilage score. Trochlea (P ¼ 0.02) and medial femoral condyle
(P ¼ 0.008) cartilage worsened more in contralateral knees than
control knees. At baseline contralateral knees had signiﬁcantlyTable IIb
Baseline characteristics. 2B. Knee KeL grade by baseline THA status. 1 vs 2, P ¼ 0.04 1 v
arthroplasty; KeL ¼ KellgreneLawrence
BL KL grade Subjects with unilateral THA
1. All contralateral knees 2. All ipsilateral knees 3. Rig
0e1 50/100% (15/30) 70/100% (21/30) 43/10
2 23/100% (7/30) 20/100% (6/30) 21/10
3 17/100% (5/30) 7/100% (2/30) 29/10
4 10/100% (3/30) 3/100% (1/30) 7/100
Knees (n) 30 30 14
* Only right knees are included in analyses of differences in T2 relaxation times.worse scores than ipsilateral knees at the trochlea (2.6 ± 0.3 vs
1.7 ± 0.3, P < 0.001), lateral femoral condyle (1.7 ± 0.3 vs 1.0 ± 0.3,
P¼ 0.02), and lateral tibia (2.1 ± 0.3 vs 1.4 ± 0.3, P¼ 0.02) andworse
scores compared control knees at the lateral femoral condyle
(P ¼ 0.03). Plate-speciﬁc cartilage results were essentially un-
changed by additional adjustment for baseline KeL grade (change
contralateral vs control: trochlea, P ¼ 0.02, medial femoral condyle,
P ¼ 0.01; baseline contralateral vs ipsilateral: trochlea, P ¼ 0.05,
lateral femoral condyle, P ¼ 0.04, lateral tibia, P ¼ 0.10; baseline
contralateral vs control: lateral femoral condyle, P ¼ 0.04).
Cartilage T2 relaxation time measurements
T2 relaxation time measurements were only available in right
knees so all comparisons are non-paired between different sub-
jects, adjusting for covariates in a multivariate regression model
(contralateral, n ¼ 14; ipsilateral, n ¼ 16; controls, n ¼ 30; Fig. 1;
Table V). The increase in T2 of the whole knee over 4 years was
signiﬁcantly greater in contralateral compared to ipsilateral knees
(2.9 ± 0.9 ms vs 0.4 ± 0.8 ms, P ¼ 0.02) and compared to control
knees (2.9 ± 0.9 ms vs 0.3 ± 0.7 ms, P < 0.001). T2 in contralateral
medial femoral condyles increased more compared to ipsilateral
(3.7 ± 1.0 ms vs 0.5 ± 0.8 ms, P ¼ 0.004) and compared to control
knees (3.7 ± 1.0 ms vs 0.2 ± 0.7 ms, P¼ 0.001). At baseline, cartilage
T2 relaxation times were non-signiﬁcantly higher in contralateral
knees (all P > 0.05; Table V). Results for T2 were essentially un-
changed by additional adjustment for baseline KeL grade
(Contralateral vs ipsilateral whole knee T2; change, P ¼ 0.006;
baseline, P ¼ 0.64).
Isometric upper leg strength
Isometric extension strength decreased signiﬁcantly more in
contralateral compared to ipsilateral knees (51.6 ± 21.9
vs 15.5 ± 22.4, P ¼ 0.04) and compared to control knees
(P ¼ 0.009), but there were no differences in change in ﬂexion
strength (P¼ 0.52 and P¼ 0.12; Table VI). Therewere no differences
in baseline strength between groups. These results were essentially
unchanged when KeL grade was included as a covariate (Changes 5, P ¼ 0.04; 3 vs 4, P ¼ 0.02; 3 vs 5, P ¼ 0.04; 4 vs 5, P ¼ 0.56. THA ¼ Total hip
No THA (controls)
ht contralateral knees* 4. Right ipsilateral knees* 5.Rt knees
0% (6/14) 75/100% (12/16) 73/100% (22/30)
0% (3/14) 19/100% (3/16) 10/100% (3/30)
0% (4/14) 6/100% (1/16) 17/100% (5/30)
% (1/14) 0/100% (0/16) 0/100% (0/30)
16 30
Table III
Baseline Knee pain and MRI ﬁndings, and change, in knees contralateral and ipsilateral to THA. Adjusted mean baseline values and adjusted mean changes over
4years ± standard error of the mean (S.E.M.) for WOMAC andWORMS scores by THA status. Contralateral vs ipsilateral knee comparisons are paired within subject differences.
Contralateral compared to right knees of subjects with No THA are adjusted means from multivariate linear regression models, adjusted for age, gender, PASE, BMI and risk
factors
Baseline Unilateral THA No THA) (controls)
right knee
Contralateral vs ipsilateral Contralateral vs control
Contralateral knee Ipsilateral knee P-value (paired
t-test)*
Paired difference
(95% CI)*
P-valuey
(95% CI)
Adj. mean difference
(95% CI)y
WOMAC Total score 8.4 ± 2.3 5.9 ± 2.2 8.8 ± 2.3 0.29 2.4 (2.1; 6.9) 0.38 2.3 (7.6; 2.9)
Pain 1.9 ± 0.5 1.3 ± 0.5 2.0 ± 0.6 0.20 0.6 (0.3; 1.5) 0.42 0.5 (1.8; 0.8)
Stiffness 1.1 ± 0.4 1.0 ± 0.4 1.5 ± 0.4 0.61 0.2 (0.5; 0.8) 0.16 0.6 (1.4; 0.2)
Function 5.7 ± 1.7 4.1 ± 1.7 5.3 ± 1.7 0.39 1.5 (2.0; 5.0) 0.56 1.2 (5.1; 2.8)
WORMS Total score 28.1 ± 2.4 21.3 ± 2.4 19.7 ± 2.4 0.008 6.8 (1.9; 11.7) 0.07 5.4 (0.4; 11.1)
Med. meniscus 2.9 ± 0.4 2.0 ± 0.4 1.7 ± 0.4 0.01 0.8 (0.0; 1.6) 0.06 0.8 (0.0; 1.6)
Lat. meniscus 2.0 ± 0.4 1.6 ± 0.4 0.9 ± 0.4 0.28 0.4 (0.3; 1.1) 0.05 0.9 (0.0; 1.9)
Ligaments 3.8 ± 0.7 3.0 ± 0.7 3.8 ± 0.7 0.25 3.0 (0.6; 2.1) 0.59 0.4 (2.0; 1.1)
Cartilage 13.4 ± 1.2 10.1 ± 1.2 8.9 ± 1.3 0.007 3.4 (1.0; 5.8) 0.04 3.1 (0.2; 6.1)
BMEz 3.4 ± 0.6 2.6 ± 0.7 2.9 ± 0.7 0.21 0.7 (0.4; 1.9) 0.71 0.3 (1.9; 1.3)
Change baseline to 4 years
WOMAC Total score 2.0 ± 2.6 3.4 ± 2.6 2.3 ± 2.6 0.06 5.1 (0.2; 10.4) 0.13 4.8 (1.4; 11.1)
Pain 0.5 ± 0.7 0.5 ± 0.6 0.7 ± 0.7 0.09 1.0 (0.2; 2.2) 0.31 0.8 (0.8; 2.4)
Stiffness 0.0 ± 0.3 0.7 ± 0.3 0.2 ± 0.3 0.04 0.7 (0.1; 1.3) 0.34 0.4 (0.4; 1.2)
Function 1.8 ± 1.9 2.3 ± 1.9 1.5 ± 1.9 0.06 3.9 (0.1; 7.8) 0.10 2.9 (0.7; 8.5)
WORMS Total score 7.9 ± 1.1 4.6 ± 1.1 5.7 ± 1.2 0.008 3.3 (0.9; 5.7) 0.03 2.8 (0.2; 5.4)
Med. meniscus 0.8 ± 0.2 0.4 ± 0.2 0.2 ± 0.2 0.06 0.4 (0.0; 0.8) 0.009 0.6 (0.2; 1.1)
Lat. meniscus 0.6 ± 0.2 0.4 ± 0.2 0.6 ± 0.2 0.26 0.4 (0.2; 0.6) 0.70 0.1 (0.6; 0.4)
Ligaments 2.4 ± 0.5 0.8 ± 0.5 0.6 ± 0.5 0.01 0.8 (0.3; 2.8) 0.009 1.7 (0.4; 2.9)
Cartilage 3.8 ± 0.6 3.0 ± 0.6 3.2 ± 0.6 0.25 3.0 (0.6; 2.3) 0.19 1.0 (0.5; 2.5)
BMEz 0.1 ± 0.5 0.9 ± 0.5 0.6 ± 0.6 0.26 0.9 (0.6; 2.3) 0.69 0.3 (1.6; 1.0)
* Paired difference ¼ contralateralipsilateral; P-value and 95% from paired t-test.
y P-value and adjusted mean difference and 95% CI from the multivariate regression model, contralateral vs control knees. Covariates were OA risk factors including: self-
reported history of knee injury or surgery, familial predisposition of OA, deﬁned as a total knee replacement for OA in a biological parent or sibling, Heberden's nodes, age,
gender BMI and PASE score.
z BME: bone marrow edema-like lesions; P-values are given for the sum of the compartment speciﬁc BME scores. P-values for maximum BME scores: Pbaseline ¼ 0.19;
Pincrease ¼ 0.45 (ipsi-versus contralateral).
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lateral vs control, P ¼ 0.005).
Main knee outcome measures at the year 4 follow-up
At the 4 year follow-up (Fig. 2), compared to ipsilateral knees the
contralateral knees had signiﬁcantly higher WOMAC total scores
(11.5 ± 2.6 vs 3.5 ± 2.5, P ¼ 0.01); higher WORMS total scoresTable IV
Baseline MRI ﬁndings, and change, by compartment, in knees contralateral and ipsilatera
the mean (S.E.M.) for WORMS compartment-speciﬁc cartilage scores by THA status. Co
Contralateral and ipsilateral comparisons to right knees of subjects with No THA and ad
contralateral or ipsilateral knee vs No THA control knees
WORMS baseline Unilateral THA No THA Con
Contralateral
knee
Ipsilateral knee (Controls)
right knee
P-va
(pai
Patella 3.1 ± 0.4 3.0 ± 0.4 2.5 ± 0.4 0.8
Trochlea 2.6 ± 0.3 1.7 ± 0.3 1.6 ± 0.4 <0.0
MFC 2.1 ± 0.4 1.7 ± 0.4 1.5 ± 0.4 0.2
LFC 1.7 ± 0.3 1.0 ± 0.3 0.9 ± 0.3 0.0
MT 1.8 ± 0.3 1.3 ± 0.3 1.1 ± 0.3 0.2
LT 2.1 ± 0.3 1.4 ± 0.3 1.2 ± 0.3 0.0
Change baseline to 4 years
Patella 0.7 ± 0.3 0.7 ± 0.3 0.4 ± 0.3 0.9
Trochlea 0.8 ± 0.2 0.5 ± 0.2 0.3 ± 0.2 0.2
MFC 0.9 ± 0.2 0.6 ± 0.2 0.3 ± 0.2 0.3
LFC 0.5 ± 0.2 0.5 ± 0.2 0.7 ± 0.3 0.9
MT 0.7 ± 0.2 0.4 ± 0.2 0.3 ± 0.2 0.3
LT 0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.2 0.8
* Paired difference ¼ contralateralipsilateral; P-value and 95% from paired t-test.
y P-value and adjusted mean difference and 95% CI from the multivariate regression m
reported history of knee injury or surgery, familial predisposition of OA, deﬁned as a tot
gender BMI and PASE score.(35.9 ± 3.0 vs 25.8 ± 3.0, P¼ 0.001; total maximumWORMS scores,
P¼ 0.001) and higher whole knee T2 values (39.8 ± 0.9 vs 36.1 ± 0.7,
P < 0.001), while extension and ﬂexion strength did not differ be-
tween groups (286 ± 23.4 vs 332 ± 23.9, P ¼ 0.12 and 144 ± 12 vs
131 ± 12, P¼ 0.43). At the 4 year follow-up, contralateral knees also
had signiﬁcantly (all P < 0.05) worse scores for WOMAC pain,
stiffness and function subscale scores, worse scores for WORMS
cartilage, medial meniscus and bonemarrow lesion subscale scores,l to THA. Adjusted mean baseline values and change over 4years ± standard error of
ntralateral vs ipsilateral knee comparisons are paired, within subject differences.
justed mean values are from multivariate linear regression models.* ¼ P < 0.05 for
tralateral vs ipsilateral Contralateral vs control
lue
red t-test)*
Paired
difference (95% CI)*
P-valuey Adj mean
difference (95% CI)y
0 0.1 (0.6; 0.7) 0.16 0.6 (3; 1.5)
01 1.0 (0.5; 1.4) 0.13 0.6 (0.2; 1.5)
6 0.4 (0.3; 1.1) 0.65 0.2 (0.7; 1.1)
2 0.8 (0.2; 1.3) 0.03 0.7 (0.1; 1.4)
1 0.5 (0.3; 1.3) 0.43 0.3 (0.5; 1.0)
2 0.7 (0.1; 1.3) 0.05 0.6 (0.0; 1.3)
4 0.0 (0.5; 0.5) 0.20 0.4 (0.2; 1.0)
5 0.3 (0.2; 0.7) 0.02 0.5 (0.1; 1.0)
1 0.2 (0.2; 0.7) 0.008 0.7 (0.2; 1.2)
4 0.0 (0.4; 0.5) 0.32 0.3 (0.9; 0.3)
2 0.3 (0.3; 0.9) 0.05 0.5 (0.0; 1.0)
7 0.0 (0.4; 0.4) 0.82 0.0 (0.4; 0.4)
odel, contralateral vs control knees. Covariates were OA risk factors including: self-
al knee replacement for OA in a biological parent or sibling, Heberden's nodes, age,
Fig. 1. T2 relaxation time color maps of right knees of individuals with ipsilateral and contralateral THA, overlaid with the ﬁrst-echo images of the MSME sequence. Blue color
indicates low, red color high cartilage T2 values. The most severe cartilage, medial meniscus and bone marrow pathologies were found in individuals with contralateral THA.
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and lateral tibia (data not shown). Results were essentially un-
changed in models that included baseline KeL grade.
Discussion
In individuals with a prevalent THA and two native knees, we
found that some, but not all, measures of degenerative morpho-
logical and T2 cartilage abnormalities assessed by knee MRI and
knee strength showed greater worsening over 4 years in the kneeTable V
Adjusted mean baseline values ± S.E.M. and 4 year change for the T2 relaxation time (ms). P
with right ipsilateral knees of different subjects with unilateral THA and comparing right c
no THA. MFC ¼Medial femoral condyle; LFC ¼ Lateral femoral condyle; MT ¼Medial tibia
knees
T2 relaxation time baseline Unilateral THA No THA C
Contralateral
right knee
Ipsilateral
right knee
(Controls)
right knee
P
Global 37.0 ± 0.8 35.9 ± 0.6 36.0 ± 0.6 0
Patella 37.5 ± 1.4 36.5 ± 1.1 36.3 ± 1.0 0
MFC 39.8 ± 1.2 38.5 ± 0.9 38.7 ± 0.9 0
LFC 36.3 ± 0.9 35.0 ± 0.7 34.9 ± 0.7 0
MT 37.7 ± 1.2 36.5 ± 0.9 36.6 ± 0.8 0
LT 33.5 ± 1.3 32.8 ± 1.0 32.0 ± 0.9 0
Change baseline to 4 years
Global 2.9 ± 0.9 0.4 ± 0.8 0.3 ± 0.7 0
Patella 5.3 ± 2.1 1.3 ± 1.7 0.6 ± 1.5 0
MFC 3.7 ± 1.0 0.5 ± 0.8 0.2 ± 0.7 0
LFC 2.7 ± 1.1 0.7 ± 0.8 0.8 ± 0.7 0
MT 0.3 ± 1.4 0.7 ± 1.1 0.7 ± 1.0 0
LT 2.3 ± 2.0 1.4 ± 1.6 0.7 ± 1.4 0
* P-value and adjusted mean difference and 95% CI from the multivariate regression mo
surgery, familial predisposition of OA, deﬁned as a total knee replacement for OA in a bicontralateral to the THA compared to these individuals' knees
ipsilateral to the THA and compared to control knees of individuals
without a THA. These ﬁndings are generally consistent with the
hypothesis that prevalent unilateral THA, increases the risk of
developing OA in the knee contralateral to the THA.
OA of one large joint is known to be associated with degener-
ative changes in other large joints within an individual2, with the
contralateral side of the same joint being at risk for OA andwith the
contralateral side of the other big joint also having an increased risk
for OA2,3. Individuals with a joint replacement are likely to have a-values are frommultivariate regression models comparing right contralateral knees
ontralateral knees of unilateral THA subjects with right knees of control subjects with
; LT ¼ Lateral tibia.* ¼ P < 0.05 for contralateral or ipsilateral knee vs No THA control
ontralateral vs ipsilateral Contralateral vs control
-value* Adj mean difference
(95% CI)*
P-value* Adj mean difference
(95% CI)*
.42 0.7 (1.0; 2.4) 0.60 0.4 (1.1; 2.0)
.84 0.3 (2.7; 3.2) 0.51 0.9 (1.8; 3.6)
.51 0.8 (1.7; 3.4) 0.43 0.9 (1.4; 3.3)
.08 1.7 (0.2; 3.7) 0.06 1.8 (0.0; 3.6)
.74 0.4 (2.1; 2.9) 0.76 0.3 (1.9; 2.6)
.43 1.1 (1.7; 3.9) 0.28 1.4 (1.2; 3.9)
.02 2.5 (0.5; 4.5) 0.001 2.4 (1.6; 5.2)
.20 2.9 (1.6; 7.4) 0.10 3.5 (0.6; 7.6)
.004 3.2 (1.6; 5.3) 0.001 3.4 (1.4; 5.3)
.14 1.7 (0.6; 3-9) 0.07 1.9 (0.2; 3.9)
.73 0.5 (2.4; 3.4) 0.94 0.1 (2.6; 2.8)
.09 3.7 (0.6; 7.9) 0.36 1.8 (2.1; 5.7)
del. Covariates were OA risk factors including: self-reported history of knee injury or
ological parent or sibling, Heberden's nodes, age, gender BMI and PASE score.
Table VI
Baseline and change in isometric extension and ﬂexion strength in knees contralateral and ipsilateral to THA. Adjusted mean baseline isometric values and change over
4years ± standard error of the mean (S.E.M.) (Newtons) for isometric strength by THA status. Contralateral vs ipsilateral knee comparisons are paired, within subject differences.
Contralateral and ipsilateral comparisons to right knees of subjects with No THA and adjusted mean values are from multivariate linear regression models
Maximum isometric strength
(Newtons) baseline:
Unilateral THA No THA (controls)
right knee
Contralateral vs ipsilateral Contralateral vs control
Contralateral
knee
Ipsilateral
knee
P-value
(paired t-test) *
Paired difference
(95% CI)*
P-valuey Adj mean difference
(95% CI)y
Extension 334.1 ± 26.1 327.0 ± 25.9 340.9 ± 26.1 0.64 7.1 (37.3; 23.2) 0.90 3.6 (65.7; 33.7)
Flexion 137.7 ± 15.6 138.1 ± 15.5 131.6 ± 15.6 0.94 0.4 (9.7; 10.5) 0.72 0.6 (39.3; 27.2)
Change: baseline to 4 years
Extension 51.6 ± 21.9 15.5 ± 22.4 4.1 ± 21.8 0.04 42.0 (2.8; 81.1) 0.009 73-3 (127.4; 19.3)
Flexion 33.9 ± 16.1 44.7 ± 16.3 58.7 ± 16.0 0.52 11.3 (46.8; 24.2) 0.12 30.1 (67.8; 7.6)
* Paired difference ¼ contralateralipsilateral; P-value and 95% from paired t-test.
y P-value and adjusted mean difference and 95% CI from the multivariate regression model, contralateral vs control knees. Covariates were OA risk factors including: self-
reported history of knee injury or surgery, familial predisposition of OA, deﬁned as a total knee replacement for OA in a biological parent or sibling, Heberden's nodes, age,
gender BMI and PASE score.
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side3,29. Umeda et al. reported increasing radiographic degenerative
changes at the contralateral medial knee compartment after uni-
lateral THA, although there was no difference between the ipsi-
lateral and contralateral knee at baseline5. Causes for an increased
progression of degenerative changes at the knee contralateral to
the THA were not investigated in the present study. Despite, po-
tential factors include biomechanical and neuromuscular factors24,
such as muscle weakness25e27. Increased peak dynamic knee loads
and increased medial compartment tibial bone mineral density in
the knee contralateral to end stage hip OA was described previ-
ously28. Gillam et al. stated, that the consequence of gait alterations
due to a diseased hip or leg length discrepancy may be responsible
for the subsequent development of OA in the contralateral knee29.
A reduced offset of conventional femoral prostheses may be
responsible for shifts in mechanical axes. Increased dynamic loads
and elevated knee adduction moments in the knee contralateral to
a THA have been found30. Foucher et al. found that the peak
adduction moment was higher on the contralateral vs the ipsilat-
eral knee in patients with unilateral THA31. The authors concluded,
that implant positioning could inﬂuence the biomechanical risk ofFig. 2. Mean values at 4-year follow-up ± S.E.M. for the parameters total WOMAC score, total
(Force; N) in knees contralateral and ipsilateral to THA. *P < 0.05 in a multivariate regressiknee OA progression after THA. On the other hand, Metcalfe et al.
reported, that also patients with knee OA had signiﬁcant increases
in adduction moment impulse at both knees and the contralateral
hip32. Alternatively to altered lower limb biomechanics, knee
injury, disease and pathomechanics could precede and may lead to
altered hip mechanics and hip OA.
Previous studies of this topic however have several limitations.
Some focused only on whether replacement of one hip or knee
affects the risk of contralateral joint replacement3,33. Other studies
have been cross-sectional2,33. Two studies have examined longi-
tudinal changes of hip or knee OA contralateral to the same joint
with OA. Spector et al.34 found that over a third of women with
unilateral radiographic knee OA will have incident or worsening
OA in other knee within 2 years. Vossinakis et al.35 found that
patients with idiopathic OA of one hip are at increased risk of
developing OA in the other hip. These studies evaluated plain ra-
diographs and did not address hipeknee or kneeehip associations,
although MRI can provide substantially more detailed information
about joint tissue damage36,37. Additionally, it is important to
evaluate both structural changes and clinical symptoms because
they often deviate38.WORMS score, global T2 relaxation time (ms), and isometric strength in knee extension
on model, adjusted for age, gender, PASE, BMI and OA risk factors.
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longitudinal progression over 4 years of knee joint ﬁndings that
occurred subsequent to unilateral THA. Adjustment for baseline
KeL grades had little or no impact on any these associations.
Greater increases in T2 values were found for contralateral knees.
WOMAC scores also showed consistent but nonsigniﬁcantly greater
progression in contralateral knees. Of note, WOMAC scores
improved in ipsilateral knees over time. Possibly, this may be due to
speciﬁc physiotherapy for this extremity or transferred symptoms
(hip complaints transferred to knee complaints) may have resolved
over time. Also, replacing one major lower extremity joint may
improve the overall lower extremity biomechanics, neuromuscular
control andmay therefore impact function and loading of the entire
extremity. Contralateral knees showed greater worsening over
4 years than ipsilateral knees and than control knees in overall
degenerative morphological changes. Surprisingly, 4-year change
in cartilage WORMS score and in bone marrow lesion WORMS
score was not signiﬁcant. This may be either due to the small
sample size or due to ceiling effects, since cartilage and bone
marrow lesionWORMS scores were higher in contralateral knees at
baseline (Table III).
Our ﬁndings for contralateral compared to ipsilateral knees
differed somewhat for cartilage morphological damage and T2
relaxation times. T2 relaxation time detects early degenerative
changes of the biochemical composition of cartilage, mainly
collagen disruption and increase of the water content14,39,40.
Therefore is able to detect cartilage changes independently of
morphological substance loss8,9. But T2 may be less sensitive than
WORMS in assessing progression in more advanced stages when
large areas of cartilage are lost40,41. The medial compartments of
contralateral knees had consistently greater worsening than the
lateral compartment in WORMS cartilage and meniscus scores and
T2 values. This pattern is consistent with increases in loading in the
medial compartment of contralateral knees associated with end-
stage hip OA30.
We observed a signiﬁcantly greater decline in knee extension
strength in limbs contralateral to THA, which may have several
explanations. First, it is consistent with the trends seen for in-
creases in WOMAC scores and signiﬁcantly greater symptoms at
year 4 in contralateral limbs, since knee pain can result in loss of
strength42e44. Altered gait patterns in persons with endstage hip
OA may also contribute to contralateral quadriceps weakeness43,45.
Weakness in the contralateral limb may contribute to an increased
risk of OA progression and thus a vicious cycle of worsening46e48.
Our study has several limitations. Since the time-point of THA
implantation was not known for all subjects, results were not
adjusted for this parameter. However, the strength of the present
study is the longitudinal study design. All observations clearly
occured after THA implantation. It is possible that pre-existing knee
OA preceded and may be associated with clinical and MRI ﬁndings
at baseline and with worsening of these outcomes during follow-
up. Due to concern about introducing collider selection bias when
adjusting for a variable (preexisting knee OA) thatmay be a result of
unilateral hip OA and THA, adjustment for baseline KeL grade was
limited to sensitivity analyses. Not surprisingly, in the cross-
sectional analyses this adjustment had the effect of attenuating
associations of unilateral THAwith knee OA outcomes. Importantly,
associations of THA with changes in knee OA outcomes in longi-
tudinal analyses were unchanged by adjusting for KeL grade,
indicating that the effect of unilateral THA on these outcomes is
independent of preexisting knee OA.
Although we included all subjects with a unilateral THA at
baseline, the precision of our study is limited by small numbers and
this is reﬂected in wide conﬁdence intervals. While this should not
affect statistically signiﬁcant results, it may have contributed to alack of statistical signiﬁcance in some instances, for example,
comparison of paired difference changes in WOMAC scores. On the
other hand our subjects are from a large community-based cohort
and represent a diverse sample of those with unilateral hip OA
treated in many different health care settings, which enhances the
generalizability of our results.
In conclusion, in individuals with a prevalent unilateral THA and
two native knees, we found moderate evidence for worse clinical
and structural outcomes assessed by MRI in the knees contralateral
to the THA compared to ipsilateral knees in the same individuals
and compared to control knees in persons with a THA. These
ﬁndings are consistent with the hypothesis that endstage unilateral
hip OA and consequent altered lower limb biomechanics increase
the risk of developing and worsening of OA in the knee contralat-
eral to the THA. They indicate a need for strategies and in-
terventions, that likely need to start early preoperatively and to
continue post surgery, to prevent the development and worsening
of OA in the contralateral limb. However, additional studies with
larger patient populations are needed to conﬁrm the observation,
that THA leads to worsening of knee degeneration in contralateral
knees.
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